Lantheus Holdings, Inc.
Develops radiopharmaceutical products for diagnosing, treating, and monitoring diseases.
LNTH | US
Overview
Corporate Details
- ISIN(s):
- US5165441032
- LEI:
- Country:
- United States of America
- Address:
- 331 TREBLE COVE ROAD, 1862 NORTH BILLERICA
- Website:
- https://www.lantheus.com/
- Sector:
- Manufacturing
Description
Lantheus Holdings, Inc. is a leading company focused on radiopharmaceuticals, specializing in the development, manufacturing, and commercialization of precision diagnostic and therapeutic products. Its portfolio is designed to assist clinicians in the diagnosis, treatment, and monitoring of various diseases. The company provides diagnostic imaging agents, targeted radiotherapeutics, and leverages artificial intelligence solutions to enhance clinical decision-making. Lantheus's strategy is centered on a 'Find, Fight, and Follow' approach to patient care, aiming to improve outcomes by delivering critical information throughout the disease management process.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Lantheus Holdings, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Lantheus Holdings, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Lantheus Holdings, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
